中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2010年
1期
6-7
,共2页
冯留顺%徐纪中%李捷%郭文治%叶学祥%李伟
馮留順%徐紀中%李捷%郭文治%葉學祥%李偉
풍류순%서기중%리첩%곽문치%협학상%리위
门静脉高压症%分流术%断流术
門靜脈高壓癥%分流術%斷流術
문정맥고압증%분류술%단류술
Portal hypertension%Shunt%Portoazygous deverscularization
目的 探讨联合分流和断流术治疗门静脉高压症的临床效果.方法 对我院1990年5月至2008年5月采用联合分流和断流手术治疗的180例门静脉高压症病人的临床资料进行回顾性分析.结果 术前自由门静脉压力(FPP)为32.5~35.5 cm H2O(1 cm H2O=0.098 kPa);脾切除、脾腔或肠腔分流术后FPP下降为24 cm H2O;联合手术后FPP平均为24.5 cm H2O.全组无手术死亡,125例随访6个月~7年,复发出血4例,肝性脑病4例,人造血管血栓形成4例,肝功能衰竭死亡2例.结论 联合分流和断流术既保留了断流术的优点,又降低了门静脉的压力,是治疗门静脉高压症的理想术式之一.
目的 探討聯閤分流和斷流術治療門靜脈高壓癥的臨床效果.方法 對我院1990年5月至2008年5月採用聯閤分流和斷流手術治療的180例門靜脈高壓癥病人的臨床資料進行迴顧性分析.結果 術前自由門靜脈壓力(FPP)為32.5~35.5 cm H2O(1 cm H2O=0.098 kPa);脾切除、脾腔或腸腔分流術後FPP下降為24 cm H2O;聯閤手術後FPP平均為24.5 cm H2O.全組無手術死亡,125例隨訪6箇月~7年,複髮齣血4例,肝性腦病4例,人造血管血栓形成4例,肝功能衰竭死亡2例.結論 聯閤分流和斷流術既保留瞭斷流術的優點,又降低瞭門靜脈的壓力,是治療門靜脈高壓癥的理想術式之一.
목적 탐토연합분류화단류술치료문정맥고압증적림상효과.방법 대아원1990년5월지2008년5월채용연합분류화단류수술치료적180례문정맥고압증병인적림상자료진행회고성분석.결과 술전자유문정맥압력(FPP)위32.5~35.5 cm H2O(1 cm H2O=0.098 kPa);비절제、비강혹장강분류술후FPP하강위24 cm H2O;연합수술후FPP평균위24.5 cm H2O.전조무수술사망,125례수방6개월~7년,복발출혈4례,간성뇌병4례,인조혈관혈전형성4례,간공능쇠갈사망2례.결론 연합분류화단류술기보류료단류술적우점,우강저료문정맥적압력,시치료문정맥고압증적이상술식지일.
Objective To explore the therapeutic effect of combined splenocaval or mesocaval C shunt and portoazygous deverscularization for the treatment of portal hypertension. Methods The clinical datas of 180 cases of portal hypertension treated with combined procedures from May 1990 to May 2008 in our hospital were analyzed retrospectively. Results The mean free portal pressure was 32.5 -35.5 cm H2O before operation,24 cm H2O and 24.5 cm H2O after splenectomy plus splenocaval or mesocaval C shunt and combined procedure, respectively. There was no death in all patient,6 months - 7 years follow - up of 125 cases showed that 4 cases with rebleeding,4 cases with encephalopathy,4 cases with thrombosis in artificial vascular graft and 2 cases died of liver failure. Conclusions Combined shunt and portoazygous deverscularization not only decreases portal pressure but preserve hepatic blood flow to some extent, it' s one of the best choices for treating portal hypertension.